Friday , 1 March 2024
Home Health U.S. FDA to review Perrigo’s birth control pill for OTC use in November | MarketScreener
Health

U.S. FDA to review Perrigo’s birth control pill for OTC use in November | MarketScreener

(Reuters) - Perrigo Co Plc said on Monday that the U.S. Food and Drug Administration had scheduled a meeting of external experts on Nov. 18 to review the application of its daily birth control pill for over-the-counter (OTC) use.

 

Continue reading your article with a FrontPage News Subscription

Already a Subscriber? Sign In  

OR
VIEW SUBSCRIPTION OPTIONS
Support independent journalism by subscribing